Trademark search for:

IGROVII

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2016-05-27 — Application filed
2016-08-04 — Sn assigned for sect 66a appl from ib
2016-08-08 — Application filed
2016-08-12 — Application filed
2016-09-12 — Assigned to examiner
2016-09-13 — Approved for pub - principal register
2016-10-05 — Notice of publication
2016-10-25 — Published for opposition
2016-11-25 — New representative at ib received
2017-01-10 — Registered-principal register
2017-02-09 — Grant of protection created, to be sent to ib
2017-02-09 — Final disposition recorded
2017-02-09 — Final disposition recorded
2017-02-24 — Notification processed by ib
2018-10-11 — Teas change of correspondence received
2021-08-06 — Change of name/address rec'd from ib
2021-11-21 — New representative at ib received
2022-01-10 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2023-07-21 — Cancelled section 71
2023-07-21 — Final status recorded
2024-03-21 — Total invalidation of reg ext protection created
2024-04-04 — Total invalidation of reg ext protection sent to ib
2024-04-04 — Invalidation processed
2024-04-22 — Total invalidation processed by the ib

Owner Information

Novo Nordisk Health Care AG
CH

Correspondent

Novo Nordisk A/S
Novo Allé
Corporate Trademarks
Bagsværd, 2880

Filing Details

Filing Date:
2016-05-27

Status Date:
2023-07-21

Category:
Pharmaceuticals

Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.